Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (101-110 of 481) with videos related to

Pageof 49
Sort By:
Leukemia & Lymphoma|January 11, 2019
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomasJoseph Roswarski, Mark Roschewski, Christopher Melani, et al.
BMJ Open|May 21, 2015
Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trialVladimir Neychev, Seth M Steinberg, Candice Cottle-Delisle, et al.
Clinical Chemistry and Laboratory Medicine|December 14, 2011
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancersElad Sharon, Jingli Zhang, Kevin Hollevoet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenograftsRaffit Hassan, Juanita Williams-Gould, Seth M Steinberg, et al.
BJU International|September 14, 2007
Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancerJeanny B Aragon-Ching, John Gillespie, Douglas K Price, et al.
Molecular Cancer Therapeutics|May 25, 2012
TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cellsDaniel P Fitzgerald, David L Emerson, Yongzhen Qian, et al.
American Journal of Clinical Oncology|January 31, 2020
Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony-Stimulating Factor Chemotherapy for Stage II Breast CancerParisa Malekzadeh, Kenneth Cowan, Seth M Steinberg, et al.
Journal of Neuro-Oncology|July 5, 2012
Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSISean J Hipp, Emilie A Steffen-Smith, Nicholas Patronas, et al.
Molecular Cancer Therapeutics|February 20, 2007
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systemsMerrill E Goldsmith, Alian Aguila, Kenneth Steadman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Association of serum interleukin-7 levels with the development of acute graft-versus-host diseaseRobert M Dean, Terry Fry, Crystal Mackall, et al.
Pageof 49

Showing results (101-110 of 481) with videos related to

Sort By:
Pageof 49
Leukemia & Lymphoma|January 11, 2019
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomasJoseph Roswarski, Mark Roschewski, Christopher Melani, et al.
BMJ Open|May 21, 2015
Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trialVladimir Neychev, Seth M Steinberg, Candice Cottle-Delisle, et al.
Clinical Chemistry and Laboratory Medicine|December 14, 2011
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancersElad Sharon, Jingli Zhang, Kevin Hollevoet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenograftsRaffit Hassan, Juanita Williams-Gould, Seth M Steinberg, et al.
BJU International|September 14, 2007
Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancerJeanny B Aragon-Ching, John Gillespie, Douglas K Price, et al.
Molecular Cancer Therapeutics|May 25, 2012
TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cellsDaniel P Fitzgerald, David L Emerson, Yongzhen Qian, et al.
American Journal of Clinical Oncology|January 31, 2020
Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony-Stimulating Factor Chemotherapy for Stage II Breast CancerParisa Malekzadeh, Kenneth Cowan, Seth M Steinberg, et al.
Journal of Neuro-Oncology|July 5, 2012
Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSISean J Hipp, Emilie A Steffen-Smith, Nicholas Patronas, et al.
Molecular Cancer Therapeutics|February 20, 2007
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systemsMerrill E Goldsmith, Alian Aguila, Kenneth Steadman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Association of serum interleukin-7 levels with the development of acute graft-versus-host diseaseRobert M Dean, Terry Fry, Crystal Mackall, et al.
Pageof 49